• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Peloton Reportedly Moving Into Wearables with Digital Heart Rate Armband

Share:

July 1, 2021

Peloton, maker of connected fitness equipment, maybe looking into the wearable space next. According to a Bloomberg report, the publicly traded company is working on a heart-rate monitoring armband.

The tool is expected to connect with the company’s smart bikes and treadmills, as well as the company’s fitness app, according to the report.

It’s no secret that the fitness company has been interested in the wearable space for some time. In fact, Peloton does have a basic heart rate monitor that straps to a user’s chest that is listed on its website for $49.

Additionally, in March reports surfaced that the company acquired Atlas Wearables, which makes a fitness smartwatch.

WHY IT MATTERS

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The wearable space is hot right now. Three out of the five FAANG companies are now touting wearables, with Facebook reportedly working on one as well. Apple took the wearable space by storm in 2018 when it announced a de novo clearance for an atrial fibrillation-detecting algorithm and an ECG on its Apple Watch Series 4.

Google is also joining the space after acquiring Fitbit for roughly $2.1 billion. Last summer, Amazon released its Amazon Halo, a wrist-worn activity tracker and accompanying app. Other competitors in the wearable space include Samsung, Withings, and Garmin.

THE LARGER TREND

Earlier this week Peloton announced that it is launching a new corporate wellness program for businesses in the U.S., U.K., Canada, Germany, and eventually Australia.

Peloton hit a rough patch earlier this year, recalling its connected treadmills after reports of 70 injuries and one child death related to the device. This came after increasing pressure from the U.S. Consumer Product Safety Commission to take the products off the market. Originally Peloton fought back at the CPSC’s initial warnings.

The company has since rolled out a new safety feature on its Tread+ that locks the treadmill after 45 seconds of inactivity.

In May, during the company’s third-quarter earnings call the company announced that it beat its revenue expectations by $140 million, however, the company said that the treadmill recalls costing the company around $165 million.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • TerrAscend Enters Into Agreements To Acquire State Flower, An Ultra-Premium California Cannabis BrandTerrAscend Enters Into Agreements To Acquire State Flower, An Ultra-Premium California Cannabis Brand
  • 3 key ways blockchain could change radiology forever3 key ways blockchain could change radiology forever
  • Brown Gibbons Lang & Company: Technology and Scale Drive M&A in Life Science ToolsBrown Gibbons Lang & Company: Technology and Scale Drive M&A in Life Science Tools
  • Connected Care Health Services Acquires Golden State Medicare Health Plan To Align The Business Of Care With Outcomes Across CaliforniaConnected Care Health Services Acquires Golden State Medicare Health Plan To Align The Business Of Care With Outcomes Across California
  • El Camino Health Offers Personalized Chatbot to Patients with COPDEl Camino Health Offers Personalized Chatbot to Patients with COPD
  • Abbott’s Device-Controlled Deep Brain Stimulation System Receives Expanded Indication for Parkinson’s TreatmentAbbott’s Device-Controlled Deep Brain Stimulation System Receives Expanded Indication for Parkinson’s Treatment
  • Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP TechnologyValo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology
  • Express Scripts Reminds Stockholders to Vote “FOR” the Merger with CignaExpress Scripts Reminds Stockholders to Vote “FOR” the Merger with Cigna

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications